Tilaknagar Industries Grants 10.65 Lakh Stock Options Under ESOP Scheme 2025
Tilaknagar Industries has granted 10,65,000 stock options under its ESOP Scheme 2025. The grant was approved by the NRC on August 15, 2026. The exercise price is ₹382 per option, with a vesting period spanning five years and an exercise period of two years post-vesting.
The grant of employee stock options is a common compensation practice and typically has a minimal direct impact on the company's immediate financial performance or stock price, unless the quantum is exceptionally large relative to the company's size.
The announcement details the routine grant of employee stock options, which is a standard corporate practice and does not inherently indicate a positive or negative shift in the company's performance or outlook.
Tilaknagar Industries Limited (TI) has announced the grant of 10,65,000 stock options to eligible employees under its Employees Stock Option Scheme 2025. The Nomination and Remuneration Committee (NRC) of the Board of Directors approved this grant through a circular resolution passed on August 15, 2026.
The ESOP Scheme 2025 is in compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Each option, when exercised, will be convertible into one equity share of the company with a face value of ₹10. The exercise price for these stock options is set at ₹382 per option.
The vesting period for these options commences from the date of grant. Nil vesting occurs during the first year, followed by 10% upon completion of the second year, 20% upon completion of the third year, 30% upon completion of the fourth year, and 40% upon completion of the fifth year from the grant date. The exercise period will not exceed 2 years from the respective vesting period. The company also noted that the shares allotted upon exercise are not subject to any lock-in period.
What to do with a filing like this
Tilaknagar Industries Limited filed this with the NSE as a statutory disclosure, categorised under designated person disclosures. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Tilaknagar Industries Limited. Read the original for the full detail.